Vitrafy Life Sciences Ltd (ASX:VFY – Get Free Report) insider John McBain purchased 28,255 shares of the firm’s stock in a transaction dated Tuesday, March 18th. The stock was acquired at an average cost of A$1.36 ($0.86) per share, for a total transaction of A$38,426.80 ($24,167.80).
Vitrafy Life Sciences Stock Performance
Further Reading
- Five stocks we like better than Vitrafy Life Sciences
- What does consumer price index measure?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Stock Market Sectors: What Are They and How Many Are There?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 10 Best Airline Stocks to Buy
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Vitrafy Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrafy Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
